| Discovery of novel doxorubicin metabolites in MCF7 doxorubicin-resistant cells X Wang, R Hui, Y Chen, W Wang, Y Chen, X Gong, J Jin Frontiers in pharmacology 10, 1434, 2019 | 24 | 2019 |
| Identification of human UMP/CMP Kinase 1 as Doxorubicin binding target using protein microarray S Chen, X Wang, X Ye, D Ma, C Chen, J Cai, Y Fu, X Cheng, Y Chen, ... SLAS DISCOVERY: Advancing Life Sciences R&D 22 (8), 1007-1015, 2017 | 7 | 2017 |
| A comprehensive screening method for investigating the potential binding targets of doxorubicin based on protein microarray X Wang, Y Chen, J Zhu, Z Yang, X Gong, R Hui, G Huang, J Jin European Journal of Pharmacology, 173896, 2021 | 4 | 2021 |
| Relationship between CMPK1 protein and ADM caused multidrug resistance S Chen, YE Xianghui, X Wang, J Jin Chinese Pharmacological Bulletin 33 (6), 788-792, 2017 | 4* | 2017 |
| Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1 S Chen, X Wang, X Ye, J Jin Journal of Biosciences and Medicines 5 (10), 64-74, 2017 | 1 | 2017 |
| Analysis of metabolites of doxorubicin in breast cancer cell line MCF-7 CY CHEN Yu-jiao,HUI Ren-jie,WANG Xu,ZHU Jing-yu,JIA Lei,JIN Jian Chinese Pharmacological Bulletin 37 (09), 1-, 2021 | | 2021 |
| Synthesis and Evaluation of Biotinylated Small Molecular Drugs with Long Chain J Ye, X., Chen, S., Wang, X., Gong, K., & Jin Chinese Pharmaceutical Journal, 175-180, 2019 | | 2019 |
| Relationship between apolipoprotein A-Ⅱ and adriamycin resistance S Chen, X YE, J Jin, Y Chen, X Gong, X Wang Chinese Pharmacological Bulletin 34 (3), 331-336, 2018 | | 2018 |
